Streetbeat News

Earnings

FLEX

Flex has revised its FY25 revenue outlook to $24.9B-$25.5B from $25.4B-$26.4B, which is below the $25.78B estimate. Adjusted EPS is now expected to be $2.39-$2.51, slightly above the $2.41 estimate.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:13 pm

AVT

Avnet has released its Q2 sales forecast, projecting revenues between $5.40 billion and $5.70 billion, which is in line with the $5.5 billion estimate. However, the company expects diluted EPS to be between $0.80 and $0.90, below the $1.01 estimate.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:13 pm

THRY

Thryv Holdings shares declined following the release of preliminary Q3 results. The company also announced a $75 million public offering and a proposed acquisition of Keap.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:12 pm

GTES

Gates Industrial Corp (NYSE:GTES) has raised its FY2024 adjusted EPS guidance to $1.33-1.37, surpassing the analyst estimate of $1.31. The company also narrowed its FY2024 sales outlook to $3.44 billion-$3.47 billion, slightly above the $3.41 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:11 pm

FLEX

Flex has announced its Q3 revenue guidance of $6.0B-$6.4B, which is below the $6.5B estimate. However, the company expects adjusted EPS to be between $0.60-$0.66, surpassing the $0.56 estimate.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:10 pm

TRIN

Trinity Cap (NASDAQ:TRIN) reported Q3 earnings per share of $0.52, meeting analyst expectations, but down 5.45% from last year. Sales were $61.77M, beating estimates by 11.23% and up 33.01% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:10 pm

ANAB

APDN

ATRC

CALC

CUE

CVRX

ENSC

GLYC

HOOK

MTNB

SPRO

TPST

In Wednesday's pre-market session, several healthcare stocks experienced significant price movements. Ensysce Biosciences, AtriCure, CalciMedica, Matinas BioPharma, Cue Biopharma, and HOOKIPA Pharma saw notable gains, while Applied DNA Sciences, AnaptysBio, Spero Therapeutics, GlycoMimetics, Tempest Therapeutics, and CVRx experienced declines.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 12:08 pm

ABTS

Abits Group (NASDAQ:ABTS) reported $1.26 million in sales for the third quarter.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:08 pm

CRTO

GMM

HAO

RDDT

SNAP

THRY

In Wednesday's pre-market session, several communication services stocks experienced significant movements. Haoxi Health Technology, Reddit, Global Mofy AI, Snap, LQR House, and Anghami saw notable gains, while Thryv Holdings, Criteo, ZW Data Action Tech, Trump Media & Technology, Blue Hat Interactive, and Leafly Holdings experienced declines.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 12:08 pm

CRTO

GMM

HAO

RDDT

SNAP

THRY

Several communication services stocks experienced significant price movements in Wednesday's pre-market session. Notable gainers include Haoxi Health Technology, Reddit, Global Mofy AI, and Snap, with Snap's rise linked to its Q3 earnings report. On the losing side, Thryv Holdings and Criteo saw declines, with Criteo's drop associated with its Q3 earnings report.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 12:08 pm